11 studies found for:    IL-7 AND HIV
Show Display Options
Rank Status Study
1 Completed Safety Study of IL-7 in HIV-infected Patients (Inspire)
Conditions: HIV Infections;   Lymphopenia
Intervention: Drug: CYT 107
2 Completed Safety of Interleukin-7 in HIV Infected People Currently Taking Anti-HIV Drugs
Condition: HIV Infections
Intervention: Drug: Recombinant human interleukin-7
3 Terminated Study on Interleukin-7 (CYT107) in HIV Patients
Condition: HIV
Intervention: Biological: Interleukin-7
4 Completed Interluekin-7 to Treat HIV-Infected People Receiving Antiretroviral Treatment
Conditions: HIV Infections;   HIV
Intervention: Drug: IL-7
5 Terminated Randomized Study on Multiple Cycles of Interleukin-7 in HIV Patients Immune Non-responders
Condition: HIV
Intervention: Drug: CYT107
6 Completed IL-7 Receptor Polymorphisms and Immune Recovery With HAART
Condition: HIV Infections
Intervention:
7 Active, not recruiting Interleukin-7 (CYT107) Treatment of Idiopathic CD4 Lymphocytopenia: Expansion of CD4 T Cells (ICICLE)
Condition: Idiopathic CD4+ T-Lymphocytopenia
Intervention: Drug: CYT107
8 Withdrawn Lopinavir and Ritonavir in Improving Immune Response to Vaccines in Patients With Complete Remission Following A Bone Marrow Transplant for Hodgkin Lymphoma
Conditions: Hodgkin Lymphoma;   Stage I Adult Hodgkin Lymphoma;   Stage II Adult Hodgkin Lymphoma;   Stage III Adult Hodgkin Lymphoma;   Stage IV Adult Hodgkin Lymphoma
Interventions: Drug: lopinavir;   Drug: ritonavir;   Genetic: polymerase chain reaction;   Other: flow cytometry;   Other: enzyme-linked immunosorbent assay;   Other: laboratory biomarker analysis
9 Recruiting Idiopathic CD4 Lymphocytopenia
Condition: Idiopathic CD4 Lymphocytopenia
Interventions: Biological: Constitution of a biobank of frozen cells, plasma and serum samples;   Genetic: Genetic study
10 Completed Therapeutic Intensification Plus Immunomodulation in HIV-infected Patients
Condition: HIV-1 Infection
Interventions: Drug: ART Intensification;   Biological: Immunomodulation
11 Active, not recruiting Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected Patients
Condition: Chronic Hepatitis B
Interventions: Drug: CYT107+GenHevac+entecavir or tenofovir;   Drug: CYT107+ entecavir or tenofovir

Indicates status has not been verified in more than two years